{{Cite journal| doi = 10.5853/jos.2017.00395| issn = 2287-6391 (Print) 2287-6405 (Electronic) 2287-6391 (Linking)| volume = 19| issue = 3| pages = 347–355| last1 = Seiffge| first1 = D. J.| last2 = Traenka| first2 = C.| last3 = Polymeris| first3 = A. A.| last4 = Thilemann| first4 = S.| last5 = Wagner| first5 = B.| last6 = Hert| first6 = L.| last7 = Muller| first7 = M. D.| last8 = Gensicke| first8 = H.| last9 = Peters| first9 = N.| last10 = Nickel| first10 = C. H.| last11 = Stippich| first11 = C.| last12 = Sutter| first12 = R.| last13 = Marsch| first13 = S.| last14 = Fisch| first14 = U.| last15 = Guzman| first15 = R.| last16 = De Marchis| first16 = G. M.| last17 = Lyrer| first17 = P. A.| last18 = Bonati| first18 = L. H.| last19 = Tsakiris| first19 = D. A.| last20 = Engelter| first20 = S. T.| title = Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice| journal = J Stroke| date = 2017-09-08| pmid = 28877563}}